16 JUNE 2014PROOFS
IDEM Singapore 2014
IDEM Singapore 2014 saw more than 500 exhibitors from 38 countries showcasing
the latest innovations in clinical dentistry, dental technology and patient care across
every segment of the dental market, covering restorative and preventive treatments,
surgical procedures and equipment, orthodontics, endodontics, periodontics and
laboratory tools. Te IDEM Singapore trade fair was the largest staged at the Suntec
Singapore Convention and Exhibition Centre since it was refurbished, and the frst
ever to fll both foors of exhibition space covering 16,000 sqm. Te trade fair and
conference welcomed 7,842 participants from 61 countries over three and a half days.
ESRO the Swiss manufacturer of dental care products, at IDEM Singapore for the
second time, had an excellent experience according to their general manager, Mr
Patrick Sutter: “IDEM Singapore has been excellent for us. We came from Switzerland
to build contacts in Asian markets,” he said. “e’ve made some good contacts and had
some good conversations. Every contact and every discussion has been fruitful. We
do not sell direct here from the fair so the results will be afterwards, but we are
positive there will be good results. We will defnitely consider coming back.”
|||| Tom Kearney Director of Corporate Events In his new role, Kearney will help establish strong relationships with practice consultants to further build out LED Imaging’s customer base. He will also work to maximize corporate sponsorships, partnerships, and other industry relationships. Prior to joining LED Imaging, Kearney most recently served as the director of corporate events for Carestream Dental, applying his decades of corporate vents and tradeshow experience to cultivating strong relationships with customers. Kearney, an original founder of Ortho Trac software, helped establish the product as a premier orthodontic practice management software around the world in markets uch as the U.S., the United Kingdom, and Australia. His experience will serve him well as he supports LED Imaging in launching digital imaging and software products. LED IMAGING Delta Dental of New Jersey Invests in New Drug
Delta Dental of New Jersey has invested $5 million in C3 Jian, Inc. to support the company’s development of an
antimicrobial drug that targets the bacteria responsible for tooth decay. It is one of several Delta Dental member
companies and afliated organizations that have made substantial investments in C3 Jian.
C3 Jian, Inc. is a private company focused on developing proprietary drugs with a focus on improving oral healthcare.
Its lead product, called C16G2, is a proprietary peptide-based antimicrobial drug specifcally targeting Streptococcus
mutans, a bacterium responsible for dental caries, or tooth decay. Under a U.S. FDA Investigational New Drug
Application, the company recently began a Phase 2 Clinical Trial to study C16G2 formulated as a mouth rinse, as
well as a gel, for both dental tray and toothbrush applications.
“Tooth decay is the most common chronic disease of childhood, yet it’s nearly 100 percent preventable,” said
Ronald Deblinger, DMD, chairman, Board of Trustees, Delta Dental of New Jersey. “Tis new treatment has the
potential to help eradicate the disease and improve the oral health, and by connection the overall health, of people